Clinical Trial Update: DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study [Phase 4]

View source ↗

Summary

This Phase 4 DESIGN study reports results on how dietary sodium intake modulates ertugliflozin-induced changes in GFR, renal oxygenation, and systemic hemodynam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Kidney Disease
• Hypertension

Drugs mentioned

• Steglatro (ertugliflozin) (ertugliflozin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Diabetes Mellitus, Diabetic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2026-04-15